I agree with this. Anyone in RAC for the last few years has been anticipating RAC sponsored clinical trials since the SPP. Now we are rapidly approaching entering the clinic with what appears to be an incredible asset, RC220. Those who funded the SPP won't be selling now and know that fair value of RAC should be significantly north of the $3 SPP raise, so I expect little resistance.
Along with the momentum of clinical milestones and increased awareness, I think we're really heading into the space where the low SOI plays into our favour as it will get increasingly difficult and expensive to build a position as the reality of RC220 dawns on the market; per todays updated deck, a proven, previously approved and safe drug with a new multi-billion dollar market.
Good luck holders, our patience will be rewarded and patients will hopefully have access to this incredible drug.
I agree with this. Anyone in RAC for the last few years has been...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $245.4M | |||
| Open | High | Low | Value | Volume |
| $1.47 | $1.51 | $1.43 | $122.3K | 82.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 69 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.44 |
Change
0.010 ( 1.71 %) |
||||
| Open | High | Low | Volume | ||
| $1.49 | $1.50 | $1.43 | 16871 | ||
| Last updated 15.58pm 27/05/2024 ? | |||||
| RAC (ASX) Chart |